According to the Qichacha APP, recently, Panlong Xinglin New Drug Research Co., Ltd. was established, with Zhang Dezhu as the legal representative and a registered capital of 50 million yuan. The business scope includes: purchasing and selling traditional Chinese medicine in real estate; medical research and experimental development; clinical trial services for drugs; retail of pharmaceuticals; wholesale of pharmaceuticals; import and export of pharmaceuticals, etc. Qichacha's equity penetration shows that the company is jointly held by Shaanxi Panlong Health Industry Holding Co., Ltd. under Panlong Pharmaceutical and Guangdong Guangji Investment Co., Ltd